| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |